; Whereas Emory University’s Rollins School of Public Health used a national prescription database to estimate that 61,298 people were using PrEP as of 2017, the majority of whom were White men, over the age of 24, and living in the Northeast, meaning that the medication is not reaching communities of color who are at higher risk of contracting HIV; Whereas more work needs to be done to further educate the public and health care professionals about PrEP to address this disparity; Whereas the United States should continue to commit itself to the goal of eradicating HIV; and Whereas it is more cost effective to prevent diseases than to treat them: Now, therefore, be it